총 10,821건 중 1,000건 출력
, 7/100 페이지
-
61
-
Notes critiques sur une épitaphe latine de Philippes (CIL 3.186 = CLE 1233)
-
Dominicy, M.;
;
(Zeitschrift für Papyrologie und Epigraphik,
v.200,
2016,
pp.115-115)
-
62
-
METTL3-mediated m <sup>6</sup> A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p/cyclinD2 axis
-
Ji, Guo;
Wang, Xiu;
Xi, Hao;
Department of Pathology, Tongji University School of Medicine, Shanghai Tenth People’s Hospital , Shanghai, China;
(International journal of immunopathology and pharmacology,
v.37,
2023,
pp.03946320231204694)
-
63
-
LncRNA HCP5 promotes neuroblastoma proliferation by regulating miR-186-5p/MAP3K2 signal axis
-
Zhu, Kai;
Wang, Liang;
Zhang, Xiao;
Sun, Hua;
Chen, Tiantuo;
Sun, Chuancheng;
Zhang, Feng;
Zhu, Yufei;
Yu, Xiyang;
He, Xiaorui;
Su, Yilin;
Corresponding author. Tel.: +86 551 62283114.;
(Journal of pediatric surgery,
v.56,
2021,
pp.778-787)
-
64
-
HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3
-
Dong, Shanshan;
Wang, Ranran;
Wang, Hui;
Ding, Qi;
Zhou, Xiao;
Wang, Jing;
Zhang, Keqiang;
Long, Ying;
Lu, Shan;
Hong, Ting;
Ren, Huayi;
Wong, Kee;
Sheng, Xiaowu;
Wang, Yu;
Zeng, Yong;
Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China;
Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China;
Key Laboratory of Radiation Oncology, Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan China;
Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China;
Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China;
The fifth department of gynecological oncology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospita;
(Journal of experimental & clinical cancer research,
v.38,
2019,
pp.110)
-
65
-
Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases
-
Ogawa, Kazuma;
Mukai, Takahiro;
Kawai, Keiichi;
Takamura, Norito;
Hanaoka, Hirofumi;
Hashimoto, Kazuyuki;
Shiba, Kazuhiro;
Mori, Hirofumi;
Saji, Hideo;
;
(European journal of nuclear medicine and molecular imaging,
v.36,
2009,
pp.115-121)
-
66
-
3-Po-186 The effects on the lumbar disc degeneration of non operative scoliosis patients
-
Nohara, A.;
;
(Japanese Orthopaedic Association,
v.2013,
2013,
pp.S775)
-
67
-
186-GLOBAL PSYCHOLOGICAL STRESS AND SOCIAL SUPPORT 3 YEARS AFTER SOLID ORGAN TRANSPLANTATION
-
Langenbach, M;
Schmeiβ
er, N;
Kö
hle, K;
;
(Journal of psychosomatic research,
v.56,
2004,
pp.648-649)
-
68
-
P186 Prognostic role of VEGFR1–3 immunoreactivity in breast cancer patients
-
Gisterek, I.J.;
Halon, A.;
Staszek-Szewczyk, U.;
Matkowski, R.;
Szelachowska, J.;
Biecek, P.;
Lata, E.;
Szewczyk, K.;
Kornafel, J.;
;
(The Breast : official journal of the European Society of Mastology,
v.20,
2011,
pp.S40-S40)
-
69
-
Galactic Anticenter CO Survey: I. L = 178?to 186? B = 3?5 to 6?0
-
Lee, Y.;
Jung, J. H.;
Chung, H. S.;
Park, Y. S.;
;
(International Astronomical Union,
v.1996,
1996,
pp.S173-S174)
-
70
-
Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer
-
Zhang, Mingxin;
Bai, Minghua;
Wang, Li;
Lu, Ning;
Wang, Jia;
Yan, Rong;
Cui, Manli;
Yan, Honglin;
Zhang, Lingmin;
Department of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, No. 48 Feng Hao West Road, Xi’an, 710077 Shaanxi China;
Department of Health, Liaocheng People’s Hospital, Liaocheng, 252000 Shandong China;
Department of Scientific Research, The First Affiliated Hospital of Xi’an Medical University, Xi’an, Shaanxi China;
Department of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, No. 48 Feng Hao West Road, Xi’an, 710077 Shaanxi China;
Department of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, No. 48 Feng Hao West Road, Xi’an, 710077 Shaanxi China;
Department of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, No. 48 Feng Hao West Road, Xi’an, 710077 Shaanxi China;
Department of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, No. 48 Feng Hao West Road, Xi’an, 710077 Shaanxi China;
Department of Gastroenterology,;
(Cancer cell international,
v.21,
2021,
pp.114)